{
    "title": "GSK lifts annual forecasts again, powered by strong vaccine launch",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12696435/GSK-raises-annual-forecasts-strong-Arexvy-launch.html",
    "date": "2023-11-01",
    "keywords": [
        "rsv",
        "gsk",
        "arexvy",
        "stg",
        "vaccine",
        "pence",
        "bln",
        "analyst",
        "paragraph",
        "wednesday",
        "launch",
        "quarter",
        "pfizer",
        "abrysvo",
        "covid",
        "growth",
        "drug",
        "q3",
        "vs",
        "fy",
        "mln",
        "stg1",
        "comment",
        "profit",
        "time",
        "respiratory",
        "virus",
        "blockbuster",
        "medicine",
        "combination",
        "patent",
        "revenue",
        "end",
        "decade",
        "trouncing",
        "consensus",
        "strength",
        "pipeline",
        "development",
        "focus",
        "company",
        "consumer",
        "healthcare",
        "business",
        "haleon",
        "year",
        "sentiment",
        "september",
        "pharmacy",
        "chain",
        "edge",
        "shot",
        "exposure",
        "thirdquarter",
        "loss",
        "japan",
        "market",
        "moment",
        "walmsley",
        "call",
        "share",
        "effect",
        "currency",
        "increase",
        "saurymper",
        "portfolio",
        "manager",
        "asset",
        "management",
        "shareholder",
        "litigation",
        "zantac",
        "overhang",
        "delaware",
        "trial",
        "companys",
        "gmt",
        "bengaluru",
        "maggie",
        "fick",
        "editing",
        "tomasz",
        "janowski",
        "mark",
        "potter",
        "david"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}